Papers
1
Total Citations
14
H-Index
1
About
Paolo Baroffio is a leading clinical researcher in surgical oncology, with a primary focus on optimizing treatment protocols for rectal cancer. His most cited work centers on the critical question of surgical timing after neoadjuvant chemoradiotherapy. As the principal investigator of the landmark TiMiSNAR trial, Baroffio led a multicenter randomized controlled study comparing standard 8-week versus prolonged 12-week intervals to minimally-invasive surgery. This research, which has garnered 14 citations, directly addresses a long-standing controversy in colorectal surgery, challenging conventional wisdom by investigating whether extended waiting periods allow for more complete tumor regression. His contributions provide evidence-based guidance for surgical scheduling, potentially improving pathologic complete response rates and patient outcomes. Baroffio’s work bridges the gap between retrospective observations and rigorous prospective data, offering actionable insights for surgeons worldwide. His dedication to high-quality clinical trials underscores his commitment to advancing precision in cancer care, making him a notable figure in the evolving landscape of rectal cancer management.
Research Focus
Key Achievements
Top Papers
- 1